Home › Funds › Duquesne Family Office LLC › RGEN
Duquesne Family Office LLC position in RGEN
REPLIGEN CORP · Health Care
Duquesne Family Office LLC reported holding 77,400 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$14.9M, representing 0.40% of its reported portfolio and ranking #44 among its reported holdings. Duquesne Family Office LLC has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Duquesne Family Office LLC's RGEN position evolved
Duquesne Family Office LLC first disclosed a stake in RGEN in Q2 2026 at 77,400 shares (US$10.6M). The position peaked in Q3 2026 at 77,400 shares, worth US$14.9M. Across 2 filings, Duquesne Family Office LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 77,400 shares valued at US$14.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 77.40K | $10.56M | New |
| Q3 2026 | 77.40K | $14.88M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RGEN and 13F data
RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), MAVERICK CAPITAL LTD (US$272.5M), Maverick Capital (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RGEN
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M sh · $536.33M · Q3 2026
- MAVERICK CAPITAL LTD 1.42M sh · $272.48M · Q3 2026
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- RTW INVESTMENTS, LP 1.39M sh · $266.32M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.24M sh · $239.02M · Q3 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M sh · $196.25M · Q3 2026
- Stephens Investment Management Group LLC 954.52K sh · $183.49M · Q3 2026
- WASATCH ADVISORS LP 907.16K sh · $174.38M · Q3 2026
- BAMCO INC /NY/ 740.91K sh · $142.42M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 734.87K sh · $141.26M · Q3 2026
- Conestoga Capital Advisors, LLC 700.63K sh · $134.68M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 591.71K sh · $113.74M · Q3 2026
More on Duquesne Family Office LLC
FAQ
How long has Duquesne Family Office LLC held RGEN?
Duquesne Family Office LLC has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Duquesne Family Office LLC's current position in RGEN?
As of Q3 2026, Duquesne Family Office LLC holds 77.40K shares of RGEN (REPLIGEN CORP), valued at $14.88M, representing 0.40% of its reported portfolio and ranking #44.
Has Duquesne Family Office LLC been buying or selling RGEN?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC held unchanged its position in RGEN. The position peaked in Q3 2026 at 77.40K shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, MAVERICK CAPITAL LTD, Maverick Capital, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.